|
|
|
42
|
5641BT
|
C TRI 1G IV/IM INJ (EMC) CEFTRIAXONE
|
CEFTRIAXONE
|
C TRI
|
1G VIAL
|
B
|
4.89
|
4.89
|
VIAL
|
28
|
VIAL
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
AVENTA BARBADOS
|
|
08120612
|
THIRD GEN CEPHALOSPORINS
|
2026-04-01
|
2028-03-31
|
|
IV/IM
|
0
|
THIRD GEN CEPHALOSPORINS
|
|
|
|
|
40
|
5641EC
|
CEFTRIAXONE 1G IV/IM INJ (KWA/ATB)
|
CEFTRIAXONE
|
CEFTRIAXONE
|
1G VIAL
|
B
|
2.12
|
2.12
|
INJECTION
|
0
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08120612
|
THIRD GEN CEPHALOSPORINS
|
2022-04-01
|
2022-09-30
|
|
IV/IM
|
0
|
ANTI-INFECTIVE AGENTS
|
2022-03-30
|
|
|
|
41
|
5641EC
|
CEFTRIAXONE 1G IV/IM INJ (KWA) (B)
|
CEFTRIAXONE
|
CEFTRIAXONE
|
1G VIAL
|
B
|
1.63
|
1.631
|
VIAL
|
28
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08120612
|
THIRD GEN CEPHALOSPORINS
|
2024-04-01
|
2026-03-31
|
|
IV/IM
|
0
|
THIRD GEN CEPHALOSPORINS
|
|
|
|
|
40
|
5641EW
|
CEFTRIAXONE 1G IV/IM INJ (CHC/ATB)
|
CEFTRIAXONE
|
CEFTRIAXONE
|
1G VIAL
|
B
|
1.11
|
1.11
|
INJECTION
|
0
|
VIAL
|
CHC
|
CARITAS HEALTHCARE PVT LTD
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08120612
|
THIRD GEN CEPHALOSPORINS
|
2022-04-01
|
2024-03-31
|
|
IV/IM
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
5641EX
|
LACEFT 1G IV/IM INJ (LDP/AHI) CEFTRIAXONE
|
CEFTRIAXONE
|
LACEFT
|
10X1G
|
B
|
17.23
|
1.72
|
INJECTION
|
0
|
VIAL
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08120612
|
THIRD GEN CEPHALOSPORINS
|
2022-04-01
|
2024-03-31
|
|
IV/IM
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
5641EY
|
CEFUROXIME 1.5G IV/IM INJ (LDP/AHI)
|
CEFUROXIME
|
CEFUROXIME
|
10X1.5G
|
B
|
17.61
|
1.76
|
INJECTION
|
0
|
VIAL
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2022-04-01
|
2024-03-31
|
|
IV/IM
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
5641FJ
|
CEFTRIAXONE 1G IV/IM INJ (MCP) (B)
|
CEFTRIAXONE
|
CEFTRIAXONE
|
1G VIAL
|
B
|
1.3
|
1.3048
|
VIAL
|
28
|
VIAL
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08120612
|
THIRD GEN CEPHALOSPORINS
|
2024-04-01
|
2024-12-27
|
|
IV/IM
|
0
|
THIRD GEN CEPHALOSPORINS
|
|
|
|
|
41
|
5641FJ
|
CEFTRIAXONE 1G IV/IM INJ (MCP) (B)
|
CEFTRIAXONE
|
CEFTRIAXONE
|
1G VIAL
|
B
|
1.48
|
1.48
|
VIAL
|
28
|
VIAL
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08120612
|
THIRD GEN CEPHALOSPORINS
|
2024-12-28
|
2026-03-31
|
|
IV/IM
|
0
|
THIRD GEN CEPHALOSPORINS
|
2024-12-27
|
|
|
|
41
|
5641FP
|
ZINACEF 1.5G INJ (BCH) CEFUROXIME
|
CEFUROXIME
|
ZINACEF
|
1.5G VIAL
|
BQ
|
17.67
|
17.67
|
VIAL
|
10
|
VIAL
|
BCH
|
SANDOZ
|
COL
|
COLLINS LTD
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
SECOND GEN CEPHALOSPORINS
|
2023-08-10
|
|
|
|
42
|
5641FP
|
ZINACEF 1.5G INJ (BCH) CEFUROXIME
|
CEFUROXIME
|
ZINACEF
|
1.5G VIAL
|
B
|
17.67
|
17.67
|
VIAL
|
10
|
VIAL
|
BCH
|
SANDOZ
|
COL
|
AVENTA BARBADOS
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
SECOND GEN CEPHALOSPORINS
|
|
|
|
|
42
|
5641FW
|
LEEONE 1G IV/IM INJ (JLP) CEFTRIAXONE
|
CEFTRIAXONE
|
LEEONE
|
25X1G
|
B
|
25.14
|
1.01
|
VIAL
|
28
|
VIAL
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2026-04-01
|
2028-03-31
|
|
IV/IM
|
0
|
SECOND GEN CEPHALOSPORINS
|
|
|
|
|
42
|
5641FX
|
SEFTAQUICK 1G INJ (JLP) CEFTAZIDIME
|
CEFTAZIDIME
|
SEFTAQUICK
|
20X1G
|
B
|
43.49
|
2.17
|
VIAL
|
28
|
VIAL
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2026-04-01
|
2028-03-31
|
|
IV/IM
|
0
|
SECOND GEN CEPHALOSPORINS
|
|
|
|
|
40
|
5641N
|
ZINACEF 1.5G INJ (GSK/COL) CEFUROXIME
|
CEFUROXIME
|
ZINACEF
|
1.5G VIAL
|
C
|
18.38
|
18.38
|
INJECTION
|
0
|
VIAL
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
5641RV
|
CEFTAZIDIME 1G INJ (SLS) (B)
|
CEFTAZIDIME
|
CEFTAZIDIME
|
1G VIAL
|
B
|
5.36
|
5.3551
|
VIAL
|
28
|
VIAL
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08120612
|
THIRD GEN CEPHALOSPORINS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
THIRD GEN CEPHALOSPORINS
|
|
|
|
|
40
|
5642BM
|
ZINACEF 750MG INJ (GSK/COL) CEFUROXIME
|
CEFUROXIME
|
ZINACEF
|
750MG VIAL
|
C
|
11.15
|
11.15
|
INJECTION
|
0
|
VIAL
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
42
|
5642BX
|
AXIM 750MG INJ (ARP) CEFUROXIME
|
CEFUROXIME
|
AXIM
|
750MG VIAL
|
BQ
|
12.56
|
12.56
|
VIAL
|
10
|
VIAL
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08120612
|
THIRD GEN CEPHALOSPORINS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
THIRD GEN CEPHALOSPORINS
|
|
|
|
|
40
|
5642CC
|
CEFUROXIME 750MG IV/IM INJ (LDP/AHI)
|
CEFUROXIME
|
CEFUROXIME
|
10X750MG
|
BQ
|
9.13
|
0.91
|
INJECTION
|
0
|
VIAL
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2022-04-01
|
2024-03-31
|
|
IV/IM
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
5642CE
|
CEFTRIAXONE 500MG IV/IM INJ (MON/PHA)
|
CEFTRIAXONE
|
CEFTRIAXONE
|
500MG VIAL
|
B
|
1.96
|
1.96
|
INJECTION
|
0
|
VIAL
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
08120612
|
THIRD GEN CEPHALOSPORINS
|
2022-04-01
|
2024-03-31
|
|
IV/IM
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
42
|
5642CF
|
CEFTRIAXONE 500MG IV INJ (LAF)
|
CEFTRIAXONE
|
CEFTRIAXONE
|
50X500MG
|
B
|
79.78
|
1.60
|
VIAL
|
28
|
VIAL
|
LAF
|
LABORATORIOS ALFA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08120612
|
THIRD GEN CEPHALOSPORINS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
THIRD GEN CEPHALOSPORINS
|
|
|
|
|
41
|
5642CJ
|
ZINACEF 750MG INJ (BCH) CEFUROXIME
|
CEFUROXIME
|
ZINACEF
|
750MG VIAL
|
BQ
|
10.74
|
10.74
|
VIAL
|
10
|
VIAL
|
BCH
|
SANDOZ
|
COL
|
COLLINS LTD
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
SECOND GEN CEPHALOSPORINS
|
2023-08-10
|